Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_assertion type Assertion NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_head.
- NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_assertion description "[Collectively, our data indicate that ERBB2-mediated breast cancer progression requires ?-catenin signaling and can be therapeutically targeted by selective ?-catenin/CBP inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_provenance.
- NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_assertion evidence source_evidence_literature NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_provenance.
- NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_assertion SIO_000772 23720052 NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_provenance.
- NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_assertion wasDerivedFrom befree-20150227 NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_provenance.
- NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_assertion wasGeneratedBy ECO_0000203 NP927608.RAo8Nig4fFdHo8w08EEGzg1McYB8NJuXR3zZhoXH2x3j0130_provenance.